Deccan Health Care has announced the appointment of three independent directors to its board on 25.04.2026, strengthening its governance structure in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. The appointments bring diverse expertise spanning public administration, social services, and retail operations to the healthcare company's leadership.

Board Appointments Overview

The company has appointed three professionals as Additional Directors in Non-Executive Independent Director roles, each bringing distinct qualifications and experience to enhance board oversight and strategic guidance.

Director Profiles and Expertise

Mr. Bhupender Singh - Administrative Leadership

Mr. Bhupendra Singh Kataria brings over 30 years of experience as a retired Public Service Officer with extensive expertise in administration and operations. He holds BBA and MBA qualifications and has demonstrated strong capabilities in public service functions and stakeholder management. His leadership approach and administrative expertise are expected to support effective independent oversight of the company's operations.

Ms. Manju Singh - Social Impact and Community Development

Ms. Manju Singh contributes over 15 years of experience in social services and community development initiatives. She holds a B.Com degree and has actively participated in various government-led programs, including:

• Swachh Bharat Abhiyan
• Poshan Abhiyaan
• Pradhan Mantri Matru Vandana Yojana

Her experience spans health, education, hygiene, and women empowerment initiatives, demonstrating strong stakeholder engagement and community leadership capabilities that align with the company's healthcare and social impact objectives.

Ms. Pratiksha Bisht - Retail and Commercial Operations

Ms. Pratiksha Bisht brings over 10 years of specialized experience in retail space and storefront development. Her expertise encompasses retail-facing projects, including high-street retail, exhibition spaces, and commercial storefront development. She has demonstrated strong capabilities in retail operations, market analysis, and client engagement, with particular experience in curating high-visibility retail environments for brand positioning and consumer engagement.

Governance and Compliance

All three appointments have been made in accordance with Regulation 30 read with Schedule III of SEBI regulations. The company has confirmed that none of the newly appointed directors have any relationship with existing board members, ensuring independence in their oversight roles.

The appointments reflect Deccan Healthcare Limited's commitment to strengthening its board composition with professionals who bring complementary skills in administration, social impact, and commercial operations, supporting the company's healthcare business objectives and governance standards.

Deccan health care Limited has announced the resignation of two Non-Executive Independent Directors from its Board, effective March 2026. The company informed BSE Limited about these corporate governance changes in compliance with SEBI Listing Regulations.

Director Resignations and Timeline

Two key independent directors have stepped down from their positions within a day of each other. The resignations represent significant changes to the company's board composition.

Reasons for Resignation

Both directors cited personal reasons for their departure from the Board. Ms. Samhitha Kandlakunta's resignation letter dated 9th March 2026 stated her decision was due to relocation overseas for career progression. She emphasized that her decision was entirely personal with no material concerns regarding fellow directors, management, or the company's governance practices.

Ms. Karishma Patel, in her resignation letter dated 10th March 2026, cited increased workload in personal commitments and other work responsibilities as the reason for her inability to continue as Independent Director. She confirmed there were no other material reasons beyond those mentioned for her resignation.

Regulatory Compliance and Disclosures

The company has fulfilled all regulatory requirements under SEBI Listing Regulations. Key compliance aspects include:

Board Acknowledgment

The Board of Directors expressed appreciation for both directors' valuable contribution and support during their tenure as Non-Executive Independent Directors. The company acknowledged their professional service and cooperation throughout their association with Deccan Health Care Limited.

The resignations were processed in accordance with SEBI Circular No. SEBI/HO/CFD/CFDPoD-1/P/CIR/2023/123 dated 13th July 2023, with all required disclosures provided in the regulatory filing. The company has requested BSE to take the resignations on record and will arrange necessary filings with the Registrar of Companies.